Marken Opens New Chicago Location
News Nov 17, 2016
Marken has announced the opening of a new operational hub in Chicago, Illinois. The new hub expands Marken’s capabilities in the US Northeast region by joining the existing New York, Boston and Philadelphia locations. With convenient access to Chicago’s O’Hare International Airport, Marken’s Chicago team will strengthen relationships with its pharmaceutical clients and provide more operational flexibility within the Marken network.
The new location will work in concert with its clients and investigator sites to collect and ship drug products, clinical trial materials and biological samples. The Chicago station will also facilitate the growing demand for direct to patient services and reliable handling of cell and gene therapy materials. The opening of Marken’s sixth facility in the US is consistent with the company’s strategy to grow with the demand for more complex clinical services.
Julia Tarasenko, Regional Director, US North East & Canada Operations, said this about the new location, “We are very pleased to be able to expand our footprint and open a new Marken facility in Chicago. By adding Chicago to our New York, Boston and Philadelphia operational centers, we are building a stronger and more nimble network in the United States. We will now be closer to our clients in the Chicago area and offer them the same high-touch, personalised services they have come to expect from us.”
The Chicago branch brings the total number of Marken logistics locations to 45, including 10 wholly-owned and dedicated GMP depots built specifically for the clinical trial industry.
Source: Story from Marken. Please note: The content above may have been edited to ensure it is in keeping with Technology Networks' style and length guidelines.
Agent Reverses Resistance to Targeted Drug in Some LeukemiasNews
After discovering how some hematologic cancer cells manage to elude death from a targeted therapy, Dana-Farber Cancer Institute scientists have double-crossed the cancer cells with a drug that renders them vulnerable to the targeted agent.READ MORE
Uptake of Controlled Release Drug Delivery Technology Set to Increase?News
The increasing access to healthcare facilities and the bolstering need for drugs to be used orally has been driving the consumption of generic drugs among people across the world, which, in turn, is fueling the need for controlled release technology for drug delivery to suffice the availability of drugs in small dosages.READ MORE